Embattled drugmaker Valeant Pharmaceuticals International (VRX) said ailing CEO J. Michael Pearson is now on medical leave, a Monday announcement that sent the Canada-based company's shares lower in pre-market trading.
Pearson, 56, has been hospitalized in New Jersey for what the company last week characterized as severe pneumonia. He was recently transferred to a second hospital, whose name and location has not been disclosed, for continued treatment, Bloomberg News reported Sunday.
02:49 An ‘Apprentice’ Role for Trump Opens Door Wide for Questions17
19:34 CEO shift at Coca-Cola could usher in more dealmaking to refresh soda giant's growth15
17:20 Trump to stay on 'Celebrity Apprentice' in his 'spare time'33
14:34 Coca-Cola Elevating Operating Chief to CEO, Succeeding Kent15